Dr. Ahmad Al-Ghazawi was Mentioned in many International Magazines like George Washington, WIPO and Venture. you can review the articles by clicking on the below Images :

Dr. Ahmad Al-Ghazawi

Dr. Ahmad Al-Ghazawi has over 29 years  of  experience inthe  pharmaceutical   sector.  He  has  worked  with Merckand  Glaxo Smith Kline for over  seven years as a pharmaceuticalscientist,  later became the technical  and  development managerresponsible for directing, designing, and development of new andexisting   Merck   drug   delivery systems  ( DDS ).Prior to joining SmithKline he  was  a  senior  pharmaceutical   scientist  at NortonHealthcare for nearly 4 years and have been involved in designing and developing of a novel dry powder inhaler  and  breath operated inhaler that won Prince Charles’s Award for Innovation in UK,1996.

Dr. Al-Ghazawi is a member of the American Association of Pharmaceutical Scientist (AAPS); USA, the Controlled Release Society Inc.; USA, the Royal Pharmaceutical Society of Great Britain – Academy of Pharmaceutical Sciences and The Aerosol Society; UK. Dr Al-Ghazawi was a visiting lecturer teaching 2/3-year pharmaceutical chemistry students for 1998-1999 courses at the University of Kent, Canterbury, UK.

Dr. Al-Ghazawi is an inventor/co-inventor of many patents in drug delivery systems. One of his patents covers Paroxetine salt, an antidepressant drug. Paxil® (Paroxetine HCl) sells at $2.2 billion in the USA annually. Dr Al-Ghazawi received his PhD from the School of Pharmacy, University of London,-UK, B.Pharm., from Jordan University of Science and Technology- Jordan and his high school Diploma from the USA.